This insurance stock is on an impressive run. How to ride the momentum with less risk

MetLife (MET) is well-positioned in the life insurance and benefits sector, exhibiting fundamental momentum that the broader market hasn't fully priced in. Backed by scale, brand equity, and an experienced leadership team, MetLife is firing on all cylinders. Premium & Sales Growth: In Q1, MetLife's core premiums and fees grew 10%, driven largely by international and domestic demand: Asia jumped 22%, Latin America 20%, while US Group Benefits gained 15%. Unlocking Efficiency via AI: While many investors focus on AI companies, they may be ignoring how AI and technological innovation can help old economy businesses. MetLife is poised to lead the industry in margin expansion (20–25 bps annually) by keeping expense growth firmly below revenue gains. Earnings Power: Consensus estimates project nearly 25% EPS growth over the next two years, from an expected $9.94 in FY2026 to $12.40 in FY2028. Roughly 5% of the forecast EPS growth is expected from buybacks (there is just under $1.2 billion remaining in the existing buyback program). Strong recent sales, favorable group life underwriting, and rising equity markets are boosting alternative investments. ROE and Capital Management: MetLife's average ROE of 17.2% is at the upper end of its 15–17% target range. …